JPWO2023079507A5 - - Google Patents

Info

Publication number
JPWO2023079507A5
JPWO2023079507A5 JP2024526560A JP2024526560A JPWO2023079507A5 JP WO2023079507 A5 JPWO2023079507 A5 JP WO2023079507A5 JP 2024526560 A JP2024526560 A JP 2024526560A JP 2024526560 A JP2024526560 A JP 2024526560A JP WO2023079507 A5 JPWO2023079507 A5 JP WO2023079507A5
Authority
JP
Japan
Prior art keywords
rsv
molar ratio
vaccine
seq
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024526560A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024542085A (ja
JP2024542085A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/060639 external-priority patent/WO2023079507A1/en
Publication of JP2024542085A publication Critical patent/JP2024542085A/ja
Publication of JP2024542085A5 publication Critical patent/JP2024542085A5/ja
Publication of JPWO2023079507A5 publication Critical patent/JPWO2023079507A5/ja
Pending legal-status Critical Current

Links

JP2024526560A 2021-11-05 2022-11-04 呼吸器合胞体ウイルスrnaワクチン Pending JP2024542085A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163276233P 2021-11-05 2021-11-05
US63/276,233 2021-11-05
EP22315065.7 2022-03-16
EP22315065 2022-03-16
PCT/IB2022/060639 WO2023079507A1 (en) 2021-11-05 2022-11-04 Respiratory syncytial virus rna vaccine

Publications (3)

Publication Number Publication Date
JP2024542085A JP2024542085A (ja) 2024-11-13
JP2024542085A5 JP2024542085A5 (https=) 2025-11-11
JPWO2023079507A5 true JPWO2023079507A5 (https=) 2025-11-11

Family

ID=84357817

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024526560A Pending JP2024542085A (ja) 2021-11-05 2022-11-04 呼吸器合胞体ウイルスrnaワクチン

Country Status (12)

Country Link
US (1) US20230302112A1 (https=)
EP (1) EP4426343A1 (https=)
JP (1) JP2024542085A (https=)
KR (1) KR20240107146A (https=)
AR (1) AR127585A1 (https=)
AU (1) AU2022382104A1 (https=)
CA (1) CA3236924A1 (https=)
CO (1) CO2024005145A2 (https=)
IL (1) IL312334A (https=)
MX (1) MX2024005462A (https=)
TW (1) TW202346593A (https=)
WO (1) WO2023079507A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022099003A1 (en) 2020-11-06 2022-05-12 Sanofi Lipid nanoparticles for delivering mrna vaccines
WO2023018831A2 (en) 2021-08-11 2023-02-16 RNAimmune, Inc. Composition and methods of mrna vaccines against novel coronavirus infection
US12280104B2 (en) 2022-11-01 2025-04-22 RNAimmune, Inc. Composition and methods for MRNA vaccines against novel omicron coronavirus infections
CN121712487A (zh) * 2023-06-28 2026-03-20 赛诺菲巴斯德有限公司 脂质纳米颗粒配制品中的固醇类似物
WO2025003754A1 (en) * 2023-06-28 2025-01-02 Sanofi Use of glycerides for lnp formulations
WO2025024336A1 (en) * 2023-07-21 2025-01-30 RNAimmune, Inc. Compositions and methods of ribonucleic acid respiratory syncytial virus (rsv) vaccines
CN119490569A (zh) * 2023-08-16 2025-02-21 深圳瑞吉生物科技有限公司 呼吸道合胞病毒抗原性多肽、核酸、疫苗及其应用
CN119504955A (zh) * 2023-08-25 2025-02-25 深圳瑞吉生物科技有限公司 呼吸道合胞病毒抗原性多肽、核酸及疫苗
CN119979573A (zh) * 2023-11-03 2025-05-13 纳美信(上海)生物科技有限公司 一种呼吸道合胞病毒mRNA疫苗
CN120022355A (zh) * 2023-11-22 2025-05-23 长春百克生物科技股份公司 一种mRNA疫苗及其应用
CN120227354A (zh) * 2023-12-29 2025-07-01 康希诺(上海)生物研发有限公司 一种用于递送核酸的脂质纳米颗粒及其制备方法和用途
CN118440937B (zh) * 2024-04-09 2025-02-25 嘉译生物医药(杭州)有限公司 新型的人合胞病毒RSV B mRNA疫苗
CN119144620B (zh) * 2024-08-29 2025-08-19 北京康乐卫士生物技术股份有限公司 呼吸道合胞病毒mRNA疫苗及其制备方法和应用

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
ATE509102T1 (de) 1994-07-15 2011-05-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
WO1998037919A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
AU7690898A (en) 1997-05-20 1998-12-11 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
ATE356630T1 (de) 1998-04-03 2007-04-15 Univ Iowa Res Found Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
EP1751289B1 (en) 2004-05-18 2009-01-14 Alphavax, Inc. Tc-83-derived alphavirus vectors, particles and methods
US20110300205A1 (en) 2009-07-06 2011-12-08 Novartis Ag Self replicating rna molecules and uses thereof
HUE042177T2 (hu) 2009-12-01 2019-06-28 Translate Bio Inc Szteroidszármazék mRNS szállítására humán genetikai betegségekben
WO2012075040A2 (en) 2010-11-30 2012-06-07 Shire Human Genetic Therapies, Inc. mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
PL3586861T3 (pl) 2011-06-08 2022-05-23 Translate Bio, Inc. Kompozycje nanocząstek lipidowych i sposoby dostarczania mrna
KR102451116B1 (ko) 2011-10-27 2022-10-06 메사추세츠 인스티튜트 오브 테크놀로지 약물 캡슐화 마이크로스피어를 형성할 수 있는, n-말단 상에 관능화된 아미노산 유도체
US10245229B2 (en) 2012-06-08 2019-04-02 Translate Bio, Inc. Pulmonary delivery of mRNA to non-lung target cells
US9738689B2 (en) * 2013-03-13 2017-08-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion RSV F proteins and their use
CN105051213A (zh) 2013-03-14 2015-11-11 夏尔人类遗传性治疗公司 信使rna加帽效率的定量评估
US10130649B2 (en) 2013-03-15 2018-11-20 Translate Bio, Inc. Synergistic enhancement of the delivery of nucleic acids via blended formulations
SG11201510747RA (en) 2013-08-21 2016-03-30 Curevac Ag Method for increasing expression of rna-encoded proteins
ES2806575T3 (es) 2013-11-01 2021-02-18 Curevac Ag ARN modificado con propiedades inmunoestimuladoras disminuidas
KR102399799B1 (ko) 2013-12-30 2022-05-18 큐어백 아게 인공 핵산 분자
CA2927254C (en) 2013-12-30 2023-10-24 Curevac Ag Artificial nucleic acid molecules
BR112016030852A2 (pt) 2014-07-02 2018-01-16 Shire Human Genetic Therapies encapsulação de rna mensageiro
DE202015010000U1 (de) 2014-12-12 2023-07-03 CureVac SE Artifizielle Nukleinsäuremoleküle für eine verbesserte Proteinexpression
ES2897823T3 (es) 2015-04-30 2022-03-02 Curevac Ag Poli(N)polimerasa inmovilizada
ES2949540T3 (es) 2015-06-19 2023-09-29 Massachusetts Inst Technology 2,5-piperazinadionas sustituidas con alquenilo y su uso en composiciones para suministrar un agente a un sujeto o una célula
TW201729835A (zh) * 2015-10-22 2017-09-01 現代公司 呼吸道病毒疫苗
WO2017162265A1 (en) 2016-03-21 2017-09-28 Biontech Rna Pharmaceuticals Gmbh Trans-replicating rna
MX2019005470A (es) 2016-11-10 2019-11-21 Translate Bio Inc Formulación de nanopartículas lipídicas basadas en ice mejorada para el suministro de arnm.
WO2018089801A1 (en) 2016-11-10 2018-05-17 Translate Bio, Inc. Improved process of preparing mrna-loaded lipid nanoparticles
EP3595713A4 (en) * 2017-03-15 2021-01-13 ModernaTX, Inc. RESPIRATORY SYNCYTIAL VIRUS Vaccine
WO2019148101A1 (en) * 2018-01-29 2019-08-01 Modernatx, Inc. Rsv rna vaccines
BR112020019938A2 (pt) 2018-04-03 2021-01-26 Sanofi polipeptídeos antigênicos de vírus sincicial respiratório
KR20210105889A (ko) * 2018-11-09 2021-08-27 아뷰터스 바이오파마 코포레이션 지질 나노입자 제제
EP4003311A1 (en) 2019-07-23 2022-06-01 Translate Bio, Inc. Stable compositions of mrna-loaded lipid nanoparticles and processes of making

Similar Documents

Publication Publication Date Title
JPWO2023079507A5 (https=)
US20220347307A1 (en) Messenger rna vaccines and uses thereof
KR100554344B1 (ko) 소포성 복합체와 이의 제조 및 사용방법
CN102858367B (zh) 抗原或药物递送复合物
CA2359886A1 (en) Polynucleotide compositions for intramuscular and intradermal administration
JPWO2021019102A5 (https=)
JP2003526676A (ja) ワクチン用のアジュバント
US20250360195A1 (en) Respiratory syncytial virus rna vaccination
US7256180B2 (en) Compositions and methods for inducing activation of dendritic cells
JPWO2023102373A5 (https=)
JP4723097B2 (ja) サイトフェクチン二量体およびその使用方法
CN120500351A (zh) 呼吸道合胞病毒mRNA疫苗
WO2024183010A1 (zh) 一种组织选择性单组分mRNA递送载体及递送系统
RU2024115276A (ru) Рнк-вакцина против респираторно-синцитиального вируса
RU2025134895A (ru) Комбинированные вакцины на основе мрнк респираторных патогенов
WO2023169506A1 (zh) 编码新型冠状病毒S蛋白的mRNA疫苗
WO2024234756A1 (zh) 针对猫FIPV的M和N抗原构建mRNA和疫苗的方法
JPWO2023111262A5 (https=)
JP2025529906A (ja) コロナウイルスに対するワクチン
JPWO2022244825A5 (https=)
JPWO2023069498A5 (https=)
EP1283727A2 (en) Compositions and methods for inducing activation of dendritic cells
JPWO2021231854A5 (https=)
CN1582902A (zh) 一种可脑内递药的药物传递系统
RU2024117908A (ru) Вакцины против метапневмовируса человека